A $48.2 million impairment charge pulled GAAP earnings per share down to $0.11, even as the adjusted figure of $0.37 cleared consensus, and revenue, segment trends, and guidance all moved the same direction as the GAAP number.
Hormel's adjusted diluted earnings per share of $0.37 beat a $0.3541 consensus estimate. GAAP diluted EPS tells a different story: $0.11 a share, less than a third of the adjusted figure, after a $48.2 million impairment charge on an Indonesia minority investment. That gap is the fact investors need before any other part of this release makes sense.
Impairment charges of that kind are commonly excluded from adjusted results because they reflect a change in the carrying value of an asset rather than ongoing operations, a defensible reason for the adjustment to exist. It does not erase the fact that the GAAP number, the one that reflects the impairment as Hormel actually reported it, is the figure closest to what shareholders' equity absorbed this quarter.
The rest of the release does not offer much reason to lean on the more favorable of the two EPS figures. Revenue came in at $2.961 billion, below a $3.035 billion consensus estimate, a genuine miss, and fell 2.4% from a year earlier, with organic sales down 2%. The segment detail shows where the weakness concentrated: Retail revenue fell 4% (organic down 3%), and International fell 4.7% (organic down 4%), the segment hit hardest by the impairment. Foodservice was the one bright spot, up 2% (organic up 2% as well), marking its twelfth consecutive quarter of organic growth.
Guidance moved lower across nearly every metric that matters on a GAAP basis. Full-year net sales guidance was cut to $12.1 billion to $12.2 billion from $12.2 billion to $12.5 billion. Organic sales growth guidance narrowed to a range of 1% to 2%, down from 1% to 4%. GAAP diluted EPS guidance was cut sharply, to $1.06 to $1.12 from $1.28 to $1.37. Adjusted diluted EPS guidance, by contrast, moved slightly higher, to $1.45 to $1.51 from $1.43 to $1.51. That divergence is not a one-quarter artifact of the impairment. It now runs through the company's full-year outlook on both bases, and investors relying on the adjusted guidance figure alone would be modeling a materially rosier year than the GAAP guidance implies.
The market's reaction reflected the harsher of the two pictures. Shares fell 9.30% to $21.505, in a session ranging from $21.37 to $23.32 against a prior close of $23.71. The company's free cash flow remains above $700 million, and the stock carries a dividend yield near 5%, an offset investors are weighing against the guidance cut. Those figures describe a company with balance-sheet flexibility even after a difficult quarter. They do not change the fact that the quarter Hormel actually reported, on a GAAP basis, was a miss, not a beat with an asterisk.